Quest Diagnostics Inc (DGX) Stock Price, Quote & News

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 973 520 2700

Website: www.questdiagnostics.com

Address:

500 Plaza Drive, Secaucus, United States

StockAutoPro Oct. 4 at 8:34 PM

$DGX: Buy target $177.33 Sell target $188.3 Strong earnings growth potential seen in leading clinical laboratory services provider.

0 · Reply

SweepCastApp Oct. 4 at 5:31 AM

$DGX: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $185 Exp on 10/17/2025 with Premium of $48K and showing BEARISH Sentiment

0 · Reply

MoneyGroupLLC Oct. 3 at 12:20 PM

Enter: $DGX NOV 21 2025 $185 CALLS Buy in Price: $4.74 - $5.80 Take Profit: $6.35 Stop Bleeding: $4.17 ROI Potential: 34% Exit Within: 249 Minutes https://moneygroup.us/alerts

0 · Reply

JarvisFlow Oct. 2 at 2:02 PM

Barclays has adjusted their stance on Quest Diagnostics ( $DGX ), setting the rating to Equal-Weight with a target price of 185 → 190.

0 · Reply

SuperGreenToday Sep. 30 at 11:00 PM

$DGX Share Price: $190.60 Contract Selected: Jan 16, 2026 $190 Calls Buy Zone: $7.82 – $9.66 Target Zone: $14.06 – $17.18 Potential Upside: 70% ROI Time to Expiration: 107 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

highnihilism Sep. 30 at 11:47 AM

$MANU Manchester United: 91 trades, $20K vs $116K avg (0.17x !!). $19K calls / $0.7K puts. $DGX Quest Diagnostics: 29 trades, $49K vs $299K avg (0.16x !!). $19K calls / $30K puts. $SLP Simulations Plus: 39 trades, $19K vs $29K avg (0.65x). $19K calls / $0.09K puts. $NI Nisource: 44 trades, $19K vs $92K avg (0.21x). $19K calls / $0.4K puts.

0 · Reply

MoneyGroupLLC Sep. 30 at 10:29 AM

Enter: $DGX NOV 21 2025 $190 CALLS Buy in Price: $6.50 - $6.83 Take Profit: $13.00 Stop Bleeding: $5.72 ROI Potential: 100% Exit Within: 207 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Sep. 29 at 10:11 PM

$DGX: Buy target $186.84 Sell target $198.28 Strong growth prospects seen in leading diagnostic information services provider amidst increased demand for testing.

0 · Reply

Doozio Sep. 29 at 1:26 AM

$DGX 🐒🍌🧠⏰♾️

0 · Reply

MoneyGroupLLC Sep. 29 at 12:45 AM

Enter: $DGX NOV 21 2025 $190 CALLS Buy in Price: $6.50 - $7.20 Take Profit: $15.34 Stop Bleeding: $5.72 ROI Potential: 136% Exit Within: 135 Minutes https://moneygroup.us/alerts

0 · Reply

Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript

Sep 25, 2025, 10:00 AM EDT - 9 days ago

Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025

Sep 24, 2025, 8:05 AM EDT - 10 days ago

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

Sep 23, 2025, 7:07 AM EDT - 11 days ago

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

Sep 22, 2025, 8:07 AM EDT - 12 days ago

Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer

Sep 18, 2025, 9:00 AM EDT - 16 days ago

WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App

Sep 15, 2025, 6:21 PM EDT - 19 days ago

Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference

Sep 10, 2025, 1:16 PM EDT - 24 days ago

Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 9:32 AM EDT - 4 weeks ago

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Sep 2, 2025, 6:27 AM EDT - 4 weeks ago

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

Aug 26, 2025, 9:00 AM EDT - 5 weeks ago

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

Aug 25, 2025, 8:52 AM EDT - 5 weeks ago

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Aug 15, 2025, 6:14 PM EDT - 7 weeks ago

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Aug 13, 2025, 6:35 PM EDT - 7 weeks ago

Quest Diagnostics Declares Quarterly Cash Dividend

Aug 7, 2025, 9:08 AM EDT - 2 months ago

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Aug 5, 2025, 8:33 AM EDT - 2 months ago

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Jul 29, 2025, 8:52 AM EDT - 2 months ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

PACB

Jul 22, 2025, 1:10 PM EDT - 2 months ago

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Jul 22, 2025, 12:22 PM EDT - 2 months ago

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 7:17 AM EDT - 2 months ago

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Jul 22, 2025, 6:47 AM EDT - 2 months ago

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Jul 15, 2025, 7:57 AM EDT - 2 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:36 AM EDT - 2 months ago

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 9, 2025, 8:24 AM EDT - 3 months ago

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Jun 25, 2025, 9:07 AM EDT - 3 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 23, 2025, 10:52 AM EDT - 3 months ago

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Jun 10, 2025, 8:03 AM EDT - 4 months ago

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

May 20, 2025, 8:52 AM EDT - 4 months ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 16, 2025, 1:11 PM EDT - 5 months ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 13, 2025, 6:03 AM EDT - 5 months ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 3, 2025, 4:26 AM EDT - 5 months ago

Quest Diagnostics: A Leader But Waiting For Better Price

Apr 23, 2025, 1:17 PM EDT - 5 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 22, 2025, 12:09 PM EDT - 5 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 11:39 AM EDT - 5 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 7:37 AM EDT - 5 months ago

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Apr 22, 2025, 7:01 AM EDT - 5 months ago

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Apr 22, 2025, 6:43 AM EDT - 5 months ago

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Apr 9, 2025, 7:53 AM EDT - 6 months ago

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

Apr 4, 2025, 1:43 PM EDT - 6 months ago

8 Upcoming Dividend Increases During Volatile Times

AMT BKU GD KAI ORCL REIT RNP

Apr 2, 2025, 7:06 AM EDT - 6 months ago

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Apr 1, 2025, 4:23 PM EDT - 6 months ago

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Mar 19, 2025, 7:52 AM EDT - 7 months ago

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Mar 18, 2025, 9:00 AM EDT - 7 months ago

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Feb 24, 2025, 8:00 AM EST - 7 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

FMS

Feb 13, 2025, 4:54 PM EST - 8 months ago

Quest Diagnostics to Host Investor Day on March 19, 2025

Feb 12, 2025, 9:00 AM EST - 8 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAL

Jan 30, 2025, 4:14 PM EST - 8 months ago

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Jan 30, 2025, 2:35 PM EST - 8 months ago

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 6:45 AM EST - 8 months ago

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Jan 27, 2025, 8:56 AM EST - 8 months ago

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

StockAutoPro Oct. 4 at 8:34 PM

$DGX: Buy target $177.33 Sell target $188.3 Strong earnings growth potential seen in leading clinical laboratory services provider.

0 · Reply

SweepCastApp Oct. 4 at 5:31 AM

$DGX: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $185 Exp on 10/17/2025 with Premium of $48K and showing BEARISH Sentiment

0 · Reply

MoneyGroupLLC Oct. 3 at 12:20 PM

Enter: $DGX NOV 21 2025 $185 CALLS Buy in Price: $4.74 - $5.80 Take Profit: $6.35 Stop Bleeding: $4.17 ROI Potential: 34% Exit Within: 249 Minutes https://moneygroup.us/alerts

0 · Reply

JarvisFlow Oct. 2 at 2:02 PM

Barclays has adjusted their stance on Quest Diagnostics ( $DGX ), setting the rating to Equal-Weight with a target price of 185 → 190.

0 · Reply

SuperGreenToday Sep. 30 at 11:00 PM

0 · Reply

highnihilism Sep. 30 at 11:47 AM

0 · Reply

MoneyGroupLLC Sep. 30 at 10:29 AM

Enter: $DGX NOV 21 2025 $190 CALLS Buy in Price: $6.50 - $6.83 Take Profit: $13.00 Stop Bleeding: $5.72 ROI Potential: 100% Exit Within: 207 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Sep. 29 at 10:11 PM

$DGX: Buy target $186.84 Sell target $198.28 Strong growth prospects seen in leading diagnostic information services provider amidst increased demand for testing.

0 · Reply

Doozio Sep. 29 at 1:26 AM

$DGX 🐒🍌🧠⏰♾️

0 · Reply

MoneyGroupLLC Sep. 29 at 12:45 AM

Enter: $DGX NOV 21 2025 $190 CALLS Buy in Price: $6.50 - $7.20 Take Profit: $15.34 Stop Bleeding: $5.72 ROI Potential: 136% Exit Within: 135 Minutes https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Sep. 27 at 12:08 AM

Enter: $DGX OCT 17 2025 $190 CALLS Buy in Price: $2.16 - $2.27 Take Profit: $3.48 Stop Bleeding: $1.90 ROI Potential: 61% Exit Within: 83 Minutes https://moneygroup.us/alerts

0 · Reply

StockAutoPro Sep. 25 at 5:50 PM

$DGX: Buy target $182.63 Sell target $193.86 Strong earnings and increasing demand for diagnostic services indicate a bullish outlook for this DGX sector stock.

0 · Reply

MoneyGroupLLC Sep. 25 at 1:31 PM

Enter: $DGX OCT 17 2025 $190 CALLS Buy in Price: $2.30 - $2.80 Take Profit: $3.68 Stop Bleeding: $2.02 ROI Potential: 60% Exit Within: 370 Minutes https://moneygroup.us/alerts

0 · Reply

highnihilism Sep. 24 at 7:11 PM

Russell 2000 (Healthcare) → $CRNX Crinetics Pharmaceuticals $CYTK Cytokinetics $DGX Quest Diagnostics $DNLI Denali Therapeutics $EGRX Eagle Pharmaceuticals

0 · Reply

moving_beyond22 Sep. 24 at 1:31 PM

$DGX NXXT closing near highs keeps pressure on shorts clean structure tight ranges then expansion textbook trend trading

0 · Reply

highnihilism Sep. 24 at 12:32 PM

Russell 2000 (Healthcare) → $CRNX Crinetics Pharmaceuticals $CYTK Cytokinetics $DGX Quest Diagnostics $DNLI Denali Therapeutics $EGRX Eagle Pharmaceuticals

0 · Reply

Thestocktraderhubzee Sep. 24 at 12:20 PM

$DGX Guardant Health And Quest Diagnostics Collaborate To Make Guardant's Shield Blood-Based Screening Test Available To Physicians And Patients Served By Quest In US

0 · Reply

Small_time_trader Sep. 23 at 3:44 PM

$DGX FYI Quest + Epic = a lot of $$ for both sides Epic is privately held btw https://www.prnewswire.com/news-releases/quest-diagnostics-to-improve-laboratory-testing-experience-with-industry-first-epic-collaboration-302563549.html

0 · Reply

OHCF Sep. 22 at 4:14 PM

$DGX I HATE THIS COMPANY. MADE AN APPOINTMENT FOR TODAY SHOW UP THE LOCATION IS PERMANENTLY CLOSED, THEY CLOSE SATURDAY SEPTEMBER 20TH AND FAILED TO TELL ANYBODY THAT HAD AN APPOINTMENT. MOST OF MY INTERACTIONS WITH THIS COMPANY ARE USUALLY CRAPPY, EVEN IN WELL TO DO AREAS. THEY'VE BEEN SUED REPEATEDLY FOR ILLEGAL DUMPING AND OTHER CRIMES. IT'S TOO BAD THAT THIS PLACE AND LABCORP HAVE A VIRTUAL DUOPOLY ON LAB TESTING.

0 · Reply

ZacksResearch Sep. 22 at 2:52 PM

$DGX up 18.8% in the past year against the industry’s decline — can it sustain the growth momentum? 🚀 🔍 Strong M&A activity with 8 acquisitions in 2024, including LifeLabs 📈 In the second quarter of 2025, the physician channel grew 20%, driven by acquisitions and organic gains 💡 Expansion in advanced diagnostics and consumer testing offerings Find out what could drive DGX’s next breakout 👉 https://www.zacks.com/stock/news/2754725/is-quest-diagnostics-stock-a-right-pick-for-your-portfolio-now?cid=sm-stocktwits-2-2754725-body-13481&ADID=SYND_STOCKTWITS_TWEET_2_2754725_BODY_13481

0 · Reply

ZacksResearch Sep. 22 at 1:52 PM

Is $DGX the right portfolio move right now? 🤔 Zacks dives into whether Quest Diagnostics’ current setup makes it a smart buy for investors today. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2754725/is-quest-diagnostics-stock-a-right-pick-for-your-portfolio-now?cid=sm-stocktwits-2-2754725-teaser-13454&ADID=SYND_STOCKTWITS_TWEET_2_2754725_TEASER_13454

0 · Reply

MoneyGroupLLC Sep. 22 at 11:46 AM

Enter: $DGX OCT 17 2025 $185 CALLS Buy in Price: $4.01 - $4.80 Take Profit: $5.57 Stop Bleeding: $3.53 ROI Potential: 39% Exit Within: 315 Minutes https://moneygroup.us/alerts

0 · Reply

Market Cap	20.05B
Revenue (ttm)	9.87B
Net Income (ttm)	871.00M
EPS (ttm)	N/A
PE Ratio	19.33
Forward PE	18.58
Profit Margin	8.82%
Debt to Equity Ratio	0.78

Volume	1,395,200
Avg Vol	841,306
Day's Range	N/A - N/A
Shares Out	111.82M
Stochastic %K	11%
Beta	0.56
Analysts	Sell
Price Target	$189.00